Euroopan unioni - ranska - EMA (European Medicines Agency)

elan pharma international ltd. - natalizumab - maladie de crohn - les immunostimulants, - traitement de modérément à sévèrement active de la maladie de crohn pour la réduction des signes et des symptômes, et l'induction et l'entretien de réponse soutenue et de la rémission chez les patients qui n'ont pas répondu malgré une pleine et adéquate cours du traitement avec un corticostéroïde et d'un immunosuppresseur; ou une intolérance ou de contre-indications médicales à ces thérapies.

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - natalizumabum - solution à diluer pour perfusion - natalizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 52 mg. - multiple sklerose - biotechnologika

Euroopan unioni - ranska - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - sclérose en plaque - immunosuppresseurs sélectifs - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 et 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Euroopan unioni - ranska - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppresseurs - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 et 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Kanada - ranska - Health Canada

biogen canada inc - natalizumab - solution - 300mg - natalizumab 300mg - immunomodulatory agents

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - natalizumabum - solution injectable dans une seringue préremplie - natalizumabum 150 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.45 mg. - multiple sklerose - biotechnologika

Euroopan unioni - ranska - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - les cochons - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Kanada - ranska - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - fer (fumarate ferreux); cuivre (oxyde de cuivre); zinc (oxyde de zinc); chrome (chlorure de chrome); manganèse (sulfate de manganèse); molybdène (molybdate de sodium); acide ascorbique (acide ascorbique); acide folique; mononitrate de thiamine; vitanine b2; nicotinamide; chlorhydrate de pyridoxine; vitamine b12; vitamine d; biotine; acide d-pantothénique (d-pantothénate de calcium); calcium (carbonate de calcium); magnésium (oxyde de magnésium); iode (iodure de potassium); bétacarotène (provitamine a); acétate de vitamine a; acétate de dl-alpha-tocophérol - comprimé - 60mg; 2mg; 25mg; 25mcg; 5mg; 25mcg; 100mg; 1mg; 3mg; 3.4mg; 20mg; 10mg; 12mcg; 250unité; 30mcg; 10mg; 250mg; 50mg; .15mg; 1500unité; 1500unité; 30unité - fer (fumarate ferreux) 60mg; cuivre (oxyde de cuivre) 2mg; zinc (oxyde de zinc) 25mg; chrome (chlorure de chrome) 25mcg; manganèse (sulfate de manganèse) 5mg; molybdène (molybdate de sodium) 25mcg; acide ascorbique (acide ascorbique) 100mg; acide folique 1mg; mononitrate de thiamine 3mg; vitanine b2 3.4mg; nicotinamide 20mg; chlorhydrate de pyridoxine 10mg; vitamine b12 12mcg; vitamine d 250unité; biotine 30mcg; acide d-pantothénique (d-pantothénate de calcium) 10mg; calcium (carbonate de calcium) 250mg; magnésium (oxyde de magnésium) 50mg; iode (iodure de potassium) .15mg; bétacarotène (provitamine a) 1500unité; acétate de vitamine a 1500unité; acétate de dl-alpha-tocophérol 30unité - iron preparations

Kanada - ranska - Health Canada

vita health products inc - manganèse (sulfate de manganèse); bétacarotène; acétate de vitamine a; acétate de dl-alpha-tocophérol; acide ascorbique; acide folique; mononitrate de thiamine; vitanine b2; nicotinamide; chlorhydrate de pyridoxine; vitamine b12; vitamine d3; biotine; acide d-pantothénique (d-pantothénate de calcium); calcium (carbonate de calcium); iode (iodure de potassium); fer (fumarate ferreux); cuivre (oxyde de cuivre); zinc (oxyde de zinc); chrome (chlorure de chrome); molybdène (molybdate de sodium); magnésium (oxyde de magnésium) - comprimé - 5mg; 1500unité; 1500unité; 30unité; 100mg; 1mg; 3mg; 3.4mg; 20mg; 10mg; 12mcg; 250unité; 30mcg; 10mg; 250mg; .15mg; 60mg; 2mg; 25mg; 25mcg; 25mcg; 50mg - manganèse (sulfate de manganèse) 5mg; bétacarotène 1500unité; acétate de vitamine a 1500unité; acétate de dl-alpha-tocophérol 30unité; acide ascorbique 100mg; acide folique 1mg; mononitrate de thiamine 3mg; vitanine b2 3.4mg; nicotinamide 20mg; chlorhydrate de pyridoxine 10mg; vitamine b12 12mcg; vitamine d3 250unité; biotine 30mcg; acide d-pantothénique (d-pantothénate de calcium) 10mg; calcium (carbonate de calcium) 250mg; iode (iodure de potassium) .15mg; fer (fumarate ferreux) 60mg; cuivre (oxyde de cuivre) 2mg; zinc (oxyde de zinc) 25mg; chrome (chlorure de chrome) 25mcg; molybdène (molybdate de sodium) 25mcg; magnésium (oxyde de magnésium) 50mg - iron preparations

Kanada - ranska - Health Canada

general nutrition canada inc. - cuivre (chélate de cuivre et protéine végétale hydrolysée); vitamine a (palmitate de rétinol); bétacarotène (provitamine a); vitamine e (acétate de d-alpha-tocophéryle); acide ascorbique; vitamine d (cholécalciférol); vitamine b1 (mononitrate de thiamine); vitanine b2; nicotinamide; vitamine b6 (chlorhydrate de pyridoxine); vitamine b12 (cyanocobalamine); acide d-pantothénique (d-pantothénate de calcium); acide folique; iode (laminaire); calcium (phosphate de calcium (dibasique)); phosphore (phosphate de calcium (dibasique)); magnésium (oxyde de magnésium); fer (fumarate ferreux); zinc (sulfate de zinc) - comprimé - 0.5mg; 1000unité; 500unité; 12.5unité; 30mg; 100unité; 5mg; 5mg; 8.5mg; 5mg; 5mcg; 7.5mg; 0.5mg; 0.093mg; 250mg; 193.75mg; 50mg; 9mg; 7.5mg - cuivre (chélate de cuivre et protéine végétale hydrolysée) 0.5mg; vitamine a (palmitate de rétinol) 1000unité; bétacarotène (provitamine a) 500unité; vitamine e (acétate de d-alpha-tocophéryle) 12.5unité; acide ascorbique 30mg; vitamine d (cholécalciférol) 100unité; vitamine b1 (mononitrate de thiamine) 5mg; vitanine b2 5mg; nicotinamide 8.5mg; vitamine b6 (chlorhydrate de pyridoxine) 5mg; vitamine b12 (cyanocobalamine) 5mcg; acide d-pantothénique (d-pantothénate de calcium) 7.5mg; acide folique 0.5mg; iode (laminaire) 0.093mg; calcium (phosphate de calcium (dibasique)) 250mg; phosphore (phosphate de calcium (dibasique)) 193.75mg; magnésium (oxyde de magnésium) 50mg; fer (fumarate ferreux) 9mg; zinc (sulfate de zinc) 7.5mg - vitamins & minerals